The content on this site is intended for healthcare professionals only
| Patients' views on the toxicity and efficacy of a treatment | |
| What is efficacy for a patient? | |
| Which are good sources of information for patients that they can rely and trust? |
EMEA-ONC-26-00045 / March 2026
The impact of disease burden: Understanding patient priorities in aRCC
Understanding patient expectations and clinicians' goals in favourable risk aRCC patients
Combination therapeutic strategies for aRCC patients with bone metastases
Non-clear cell renal cell carcinoma: Management of papillary RCC
Treatment management of favourable risk and very favourable risk patients
Managing cardiotoxicities for RCC treatment – Cardiologist’s perspective
Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective
Durable responses in aRCC, how do we optimise treatment?
Patient expectations and shared decision making in aRCC
Safety and quality of life assessment, how do they impact patient decision? KCCure survey – part B
